• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al.

作者信息

Sarigianni Maria, Katsiki Niki, Mikhailidis Dimitri P

出版信息

Diabetes Care. 2010 Oct;33(10):e132; author reply e133. doi: 10.2337/dc10-1250.

DOI:10.2337/dc10-1250
PMID:20876706
Abstract
摘要

相似文献

1
Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al.与单用辛伐他汀相比，依折麦布与辛伐他汀联合治疗对2型糖尿病患者的影响：一项前瞻性随机双盲临床试验：对鲁杰内蒂等人研究的评论
Diabetes Care. 2010 Oct;33(10):e132; author reply e133. doi: 10.2337/dc10-1250.
2
Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial.依泽替米贝与辛伐他汀联合治疗与辛伐他汀单药治疗 2 型糖尿病患者的效果比较：一项前瞻性随机双盲临床试验。
Diabetes Care. 2010 Sep;33(9):1954-6. doi: 10.2337/dc10-0320. Epub 2010 Jun 21.
3
Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.依折麦布/辛伐他汀与辛伐他汀及阿托伐他汀在降低C反应蛋白和低密度脂蛋白胆固醇水平方面的效果比较。
Am J Cardiol. 2007 Jun 15;99(12):1706-1713. doi: 10.1016/j.amjcard.2007.01.062. Epub 2007 May 2.
4
Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial.依折麦布与辛伐他汀联合用药在中东人群中的效果：一项前瞻性、多中心、随机、双盲、安慰剂对照试验。
J Cardiovasc Med (Hagerstown). 2008 Jul;9(7):688-93. doi: 10.2459/JCM.0b013e3282f3a1b1.
5
The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.低剂量辛伐他汀与依折麦布联合用药与高剂量辛伐他汀单药治疗对代谢综合征患者脂肪负荷后内皮功能的影响：一项随机双盲交叉试验。
J Cardiovasc Pharmacol. 2008 Aug;52(2):145-50. doi: 10.1097/FJC.0b013e31817ffe76.
6
Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.依折麦布/辛伐他汀与缓释烟酸联合给药对IIa型或IIb型高脂血症患者的血脂调节疗效及安全性
J Am Coll Cardiol. 2008 Apr 22;51(16):1564-72. doi: 10.1016/j.jacc.2008.03.003.
7
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.一项多中心、随机、双盲、安慰剂对照、析因设计研究，旨在评估依折麦布/辛伐他汀片与依折麦布及辛伐他汀单药治疗相比，在原发性高胆固醇血症患者中的降脂疗效和安全性。
Clin Ther. 2004 Nov;26(11):1758-73. doi: 10.1016/j.clinthera.2004.11.016.
8
Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.依折麦布与他汀类药物联合使用治疗男性和女性高胆固醇血症时疗效和安全性的一致性。
J Womens Health (Larchmt). 2004 Dec;13(10):1101-7. doi: 10.1089/jwh.2004.13.1101.
9
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.依折麦布/辛伐他汀对原发性高胆固醇血症患者脂蛋白亚组分的影响：使用两种市售技术对存档样本进行的探索性分析。
Clin Ther. 2007 Nov;29(11):2419-32. doi: 10.1016/j.clinthera.2007.10.004.
10
Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.在患有冠心病的高胆固醇血症患者中，依折麦布与正在进行的辛伐他汀治疗联合使用对实现低密度脂蛋白胆固醇（LDL-C）目标的影响。
Int J Cardiol. 2005 Jul 10;102(2):327-32. doi: 10.1016/j.ijcard.2005.01.022.